Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease

Patients with chronic kidney disease (CKD) have an increased risk of fracture. Raloxifene is a mild anti-resorptive agent that reduces fracture risk in the general population. Here we assessed the impact of raloxifene on the skeletal properties of animals with progressive CKD. Male Cy/+ rats that de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int
Main Authors: Newman, Christopher L., Creecy, Amy, Granke, Mathilde, Nyman, Jeffry S., Tian, Nannan, Hammond, Max A., Wallace, Joseph M., Brown, Drew M., Chen, Neal, Moe, Sharon M., Allen, Matthew R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840093/
https://ncbi.nlm.nih.gov/pubmed/26489025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2015.315
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados